Literature DB >> 16521203

Small gastrointestinal stromal tumor concomitant with early gastric cancer: a case report.

Ying-Lung Lin1, Jeh-En Tzeng, Chang-Kou Wei, Chih-Wen Lin.   

Abstract

The term gastrointestinal stromal tumors (GISTs) is defined diagnostically as the main group of mesenchymal tumors with spindle or epithelioid cells arising from the wall of the gastrointestinal tract with immunohistochemical reactivity for CD117 antibody. Previous studies revealed that cells in GISTs express a growth factor receptor with tyrosine kinase activity (termed c-kit), which is the product of the c-kit proto-oncogene. The most specific and practical diagnostic criteria for GISTs are: immunohistochemically determined c-kit (CD117) expression; mitotic score; and tumor size. A small GIST concomitant with early gastric cancer is rarely encountered clinically. Herein we have reported a case of a 1.1-cm GIST detected by esophagogastroduodenoscopy concomitant with a IIc type of early gastric cancer (signet ring cell type). It was detected during a routine physical health examination. To our knowledge, this is the first report of a small GIST concomitant with a signet ring cell type of early gastric cancer.

Entities:  

Mesh:

Year:  2006        PMID: 16521203      PMCID: PMC4066140          DOI: 10.3748/wjg.v12.i5.815

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  11 in total

1.  KIT extracellular and kinase domain mutations in gastrointestinal stromal tumors.

Authors:  M L Lux; B P Rubin; T L Biase; C J Chen; T Maclure; G Demetri; S Xiao; S Singer; C D Fletcher; J A Fletcher
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  Abl protein-tyrosine kinase inhibitor STI571 inhibits in vitro signal transduction mediated by c-kit and platelet-derived growth factor receptors.

Authors:  E Buchdunger; C L Cioffi; N Law; D Stover; S Ohno-Jones; B J Druker; N B Lydon
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

Review 3.  Classes of c-KIT activating mutations: proposed mechanisms of action and implications for disease classification and therapy.

Authors:  B J Longley; M J Reguera; Y Ma
Journal:  Leuk Res       Date:  2001-07       Impact factor: 3.156

Review 4.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

5.  Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor.

Authors:  M C Heinrich; D J Griffith; B J Druker; C L Wait; K A Ott; A J Zigler
Journal:  Blood       Date:  2000-08-01       Impact factor: 22.113

6.  Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.

Authors:  W L Wang; M E Healy; M Sattler; S Verma; J Lin; G Maulik; C D Stiles; J D Griffin; B E Johnson; R Salgia
Journal:  Oncogene       Date:  2000-07-20       Impact factor: 9.867

Review 7.  Biological and clinical review of stromal tumors in the gastrointestinal tract.

Authors:  T Nishida; S Hirota
Journal:  Histol Histopathol       Date:  2000-10       Impact factor: 2.303

Review 8.  Gastrointestinal stromal tumors: biology and treatment.

Authors:  Florence Duffaud; Jean-Yves Blay
Journal:  Oncology       Date:  2003       Impact factor: 2.935

9.  Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade.

Authors:  Tadashi Hasegawa; Yoshihiro Matsuno; Tadakazu Shimoda; Setsuo Hirohashi
Journal:  Hum Pathol       Date:  2002-06       Impact factor: 3.466

10.  Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells.

Authors:  B J Druker; S Tamura; E Buchdunger; S Ohno; G M Segal; S Fanning; J Zimmermann; N B Lydon
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

View more
  21 in total

1.  Computed tomography imaging characteristics of synchronous gastrointestinal stromal tumors in patients with gastric cancer and correlation with clinicopathological findings.

Authors:  Zhenshan Shi; Qian Zhuang
Journal:  Mol Clin Oncol       Date:  2015-08-13

2.  Gastrointestinal stromal tumors and second primary malignancies before and after the introduction of imatinib mesylate.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  Chin J Cancer Res       Date:  2013-10       Impact factor: 5.087

3.  Rectal gastrointestinal stromal tumor as an incidental finding in a patient with rectal polyps.

Authors:  Yong Zhou; Xu-Dong Wu; Ren-Gen Fan; Wen-Zhang zha; Yong-Hua Xu; Cheng-Lin Qing; Jing Jia
Journal:  Int J Clin Exp Pathol       Date:  2015-05-01

4.  Synchronous gastric adenocarcinoma and gastrointestinal stromal tumor (GIST) of the stomach: a case report.

Authors:  Theodosios Theodosopoulos; Dionysios Dellaportas; Vasiliki Psychogiou; Konstantinos Gennatas; Agathi Kondi-Pafiti; Georgios Gkiokas; Ioannis Papaconstantinou; Georgios Polymeneas
Journal:  World J Surg Oncol       Date:  2011-05-26       Impact factor: 2.754

5.  The impact of incidental gastrointestinal stromal tumours on patients undergoing resection of upper gastrointestinal neoplasms.

Authors:  Carlos H F Chan; Jonathan Cools-Lartigue; Victoria A Marcus; Liane S Feldman; Lorenzo E Ferri
Journal:  Can J Surg       Date:  2012-12       Impact factor: 2.089

6.  Synchronous occurrence of gastrointestinal stromal tumors and other primary gastrointestinal neoplasms.

Authors:  Marek Wronski; Bogna Ziarkiewicz-Wroblewska; Barbara Gornicka; Wlodzimierz Cebulski; Maciej Slodkowski; Aleksander Wasiutynski; Ireneusz W Krasnodebski
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

7.  Synchronous adenocarcinoma and gastrointestinal stromal tumors in the stomach.

Authors:  Rong Cai; Gang Ren; Deng-Bin Wang
Journal:  World J Gastroenterol       Date:  2013-05-28       Impact factor: 5.742

8.  Synchronous adenocarcinoma and gastrointestinal stromal tumors of the stomach treated laparoscopically.

Authors:  Shuichiro Uchiyama; Motoaki Nagano; Nobuyasu Takahashi; Hideki Hidaka; Hiromitsu Matsuda; Koki Nagaike; Naoki Maehara; Masayuki Hotokezaka; Kazuo Chijiiwa
Journal:  Int J Clin Oncol       Date:  2007-12-21       Impact factor: 3.402

Review 9.  The Occurrence of Gastrointestinal Stromal Tumors and Second Malignancies.

Authors:  Jacopo Giuliani; Andrea Bonetti
Journal:  J Gastrointest Cancer       Date:  2015-12

10.  Synchronous incidental gastrointestinal stromal and epithelial malignant tumors.

Authors:  Yan-Jun Liu; Zhou Yang; Lang-Song Hao; Lin Xia; Qian-Bin Jia; Xiao-Ting Wu
Journal:  World J Gastroenterol       Date:  2009-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.